{
 "drug": "Morphine Sulfate Injection",
 "asOf": "2026-08-25",
 "status": "in-shortage",
 "since": "10/31/2017",
 "dayN": 3220,
 "cat": "Analgesia/Addiction",
 "companies": [
  "Hikma Pharmaceuticals USA, Inc.",
  "Fresenius Kabi USA, LLC",
  "Hospira, Inc., a Pfizer Company",
  "Piramal Critical Care Inc.",
  "Amphastar Pharmaceuticals, Inc."
 ],
 "reasons": [
  "Other",
  "Discontinuation of the manufacture of the drug",
  "Demand increase for the drug"
 ],
 "records": [
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/03/2017",
   "package_ndc": "0641-6039-01",
   "generic_name": "Morphine Sulfate Injection",
   "contact_info": "800-631-2174",
   "availability": "Available",
   "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
   "openfda": {
    "application_number": [
     "NDA018565"
    ],
    "brand_name": [
     "INFUMORPH 200"
    ],
    "generic_name": [
     "MORPHINE SULFATE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-6039",
     "0641-6040"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "EPIDURAL",
     "INTRATHECAL"
    ],
    "substance_name": [
     "MORPHINE SULFATE"
    ],
    "rxcui": [
     "892652",
     "1731522",
     "1731998",
     "1731999"
    ],
    "spl_id": [
     "b1c060cb-5c5b-495f-90b5-044e04f2a3f2"
    ],
    "spl_set_id": [
     "db9ac9e3-d761-4a99-9f34-4946ebe8f255"
    ],
    "package_ndc": [
     "0641-6039-01",
     "0641-6040-01"
    ],
    "unii": [
     "X3P646A2J0"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Infumorph 200 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 10 mg/1 mL (NDC 0641-6039-01)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/03/2017",
   "package_ndc": "0641-6126-25",
   "generic_name": "Morphine Sulfate Injection",
   "contact_info": "800-631-2174",
   "availability": "Available",
   "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
   "openfda": {
    "application_number": [
     "ANDA205758"
    ],
    "brand_name": [
     "MORPHINE SULFATE"
    ],
    "generic_name": [
     "MORPHINE SULFATE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-6126",
     "0641-6127",
     "0641-6125"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MORPHINE SULFATE"
    ],
    "rxcui": [
     "1731993",
     "1732006",
     "1732011"
    ],
    "spl_id": [
     "fb513d10-94f4-45f5-8b30-fa82ef83e4e2"
    ],
    "spl_set_id": [
     "6023606c-150c-40c5-9175-598efe2a56c3"
    ],
    "package_ndc": [
     "0641-6126-01",
     "0641-6126-25",
     "0641-6127-01",
     "0641-6127-25",
     "0641-6125-01",
     "0641-6125-25"
    ],
    "unii": [
     "X3P646A2J0"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Morphine Sulfate, Injection, 8 mg/1 mL (NDC 0641-6126-25)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "10/31/2017",
   "package_ndc": "63323-454-01",
   "generic_name": "Morphine Sulfate Injection",
   "contact_info": "888-386-1300",
   "availability": "Available",
   "related_info": "Check wholesalers for inventory",
   "openfda": {
    "application_number": [
     "NDA204223"
    ],
    "brand_name": [
     "MORPHINE SULFATE"
    ],
    "generic_name": [
     "MORPHINE SULFATE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-454",
     "63323-452",
     "63323-455",
     "63323-458",
     "63323-451"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MORPHINE SULFATE"
    ],
    "rxcui": [
     "1731993",
     "1732006",
     "1732011",
     "1732136",
     "2003714"
    ],
    "spl_id": [
     "dbf870e7-7bfe-48f0-ba6a-9cc476dfe5cc"
    ],
    "spl_set_id": [
     "582f42e5-444e-4246-af8c-e7e28097c69a"
    ],
    "package_ndc": [
     "63323-452-00",
     "63323-452-01",
     "63323-454-00",
     "63323-454-01",
     "63323-455-00",
     "63323-455-01",
     "63323-458-00",
     "63323-458-01",
     "63323-451-00",
     "63323-451-01"
    ],
    "unii": [
     "X3P646A2J0"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Morphine Sulfate, Injection, 4 mg/1 mL (NDC 63323-454-01)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "10/31/2017",
   "package_ndc": "76045-004-11",
   "generic_name": "Morphine Sulfate Injection",
   "contact_info": "888-386-1300",
   "availability": "Unavailable",
   "related_info": "Next release August 2026. Check wholesalers for inventory.",
   "openfda": {
    "application_number": [
     "NDA204223"
    ],
    "brand_name": [
     "MORPHINE SULFATE"
    ],
    "generic_name": [
     "MORPHINE SULFATE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi, USA LLC"
    ],
    "product_ndc": [
     "76045-004",
     "76045-005",
     "76045-006",
     "76045-007",
     "76045-008"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MORPHINE SULFATE"
    ],
    "rxcui": [
     "894912",
     "894914",
     "998212",
     "998213",
     "1442790"
    ],
    "spl_id": [
     "286bce70-23cd-4d5b-989b-230d6cdd5a91"
    ],
    "spl_set_id": [
     "1f53de80-efc8-4930-b3e3-fba0d026af05"
    ],
    "package_ndc": [
     "76045-004-01",
     "76045-004-11",
     "76045-005-01",
     "76045-005-11",
     "76045-006-01",
     "76045-006-11",
     "76045-007-01",
     "76045-007-11",
     "76045-008-01",
     "76045-008-11"
    ],
    "unii": [
     "X3P646A2J0"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Morphine Sulfate, Injection, 2 mg/1 mL (NDC 76045-004-11)",
   "company_name": "Fresenius Kabi USA, LLC",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "10/31/2017",
   "package_ndc": "0409-1896-20",
   "generic_name": "Morphine Sulfate Injection",
   "contact_info": "844-646-4398",
   "availability": "Unavailable",
   "related_info": "Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay",
   "openfda": {
    "application_number": [
     "NDA202515"
    ],
    "brand_name": [
     "MORPHINE SULFATE"
    ],
    "generic_name": [
     "MORPHINE SULFATE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-1896",
     "0409-2022"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MORPHINE SULFATE"
    ],
    "rxcui": [
     "1731537",
     "1731545"
    ],
    "spl_id": [
     "6f2d5741-5543-4bea-8d1d-7e4889b634a0"
    ],
    "spl_set_id": [
     "ee8057d1-ed12-4e18-9efa-d83504abf612"
    ],
    "package_ndc": [
     "0409-1896-20",
     "0409-2022-01"
    ],
    "unii": [
     "X3P646A2J0"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Morphine Sulfate, Injection, 50 mg/1 mL (NDC 0409-1896-20)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "10/31/2017",
   "package_ndc": "0409-1892-01",
   "generic_name": "Morphine Sulfate Injection",
   "contact_info": "844-646-4398",
   "availability": "Unavailable",
   "related_info": "Discontinuation of the manufacture of the drug",
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Morphine Sulfate, Injection, 8 mg/1 mL Syringes (NDC 0409-1892-01)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/03/2017",
   "package_ndc": "0641-6127-25",
   "generic_name": "Morphine Sulfate Injection",
   "contact_info": "800-631-2174",
   "availability": "Available",
   "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
   "openfda": {
    "application_number": [
     "ANDA205758"
    ],
    "brand_name": [
     "MORPHINE SULFATE"
    ],
    "generic_name": [
     "MORPHINE SULFATE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-6127",
     "0641-6126",
     "0641-6125"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MORPHINE SULFATE"
    ],
    "rxcui": [
     "1731993",
     "1732006",
     "1732011"
    ],
    "spl_id": [
     "fb513d10-94f4-45f5-8b30-fa82ef83e4e2"
    ],
    "spl_set_id": [
     "6023606c-150c-40c5-9175-598efe2a56c3"
    ],
    "package_ndc": [
     "0641-6126-01",
     "0641-6126-25",
     "0641-6127-01",
     "0641-6127-25",
     "0641-6125-01",
     "0641-6125-25"
    ],
    "unii": [
     "X3P646A2J0"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Morphine Sulfate, Injection, 10 mg/1 mL (NDC 0641-6127-25)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "10/31/2017",
   "package_ndc": "0409-1134-05",
   "generic_name": "Morphine Sulfate Injection",
   "contact_info": "844-646-4398",
   "availability": "Unavailable",
   "related_info": "Discontinuation of the manufacture of the drug",
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Morphine Sulfate, Injection, 50 mg/1 mL (NDC 0409-1134-05)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "10/31/2017",
   "package_ndc": "0409-3814-12",
   "generic_name": "Morphine Sulfate Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA073509"
    ],
    "brand_name": [
     "MORPHINE SULFATE"
    ],
    "generic_name": [
     "MORPHINE SULFATE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-3814",
     "0409-3815"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "EPIDURAL",
     "INTRATHECAL",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MORPHINE SULFATE"
    ],
    "rxcui": [
     "1728783",
     "1728800"
    ],
    "spl_id": [
     "0a2ba20b-448f-4412-9899-b82040ebfa7d"
    ],
    "spl_set_id": [
     "1d181906-f3ec-4222-1883-e61577a3122e"
    ],
    "package_ndc": [
     "0409-3814-11",
     "0409-3814-12",
     "0409-3815-11",
     "0409-3815-12"
    ],
    "unii": [
     "X3P646A2J0"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Morphine Sulfate, Injection, 5 mg/10 mL (0.5 mg/mL) (NDC 0409-3814-12)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "10/31/2017",
   "package_ndc": "66794-160-02",
   "generic_name": "Morphine Sulfate Injection",
   "contact_info": "800-414-1901",
   "availability": "Limited Availability",
   "related_info": "On allocation",
   "openfda": {
    "application_number": [
     "ANDA204393"
    ],
    "brand_name": [
     "MITIGO"
    ],
    "generic_name": [
     "MORPHINE SULFATE"
    ],
    "manufacturer_name": [
     "Piramal Critical Care, Inc."
    ],
    "product_ndc": [
     "66794-160",
     "66794-162"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "EPIDURAL",
     "INTRATHECAL"
    ],
    "substance_name": [
     "MORPHINE SULFATE"
    ],
    "rxcui": [
     "1731522",
     "1731998",
     "2055307",
     "2055311"
    ],
    "spl_id": [
     "495a6a51-d35d-2b96-e063-6394a90ac5f3"
    ],
    "spl_set_id": [
     "728f3d83-9a63-0c1f-e053-2a91aa0ac7db"
    ],
    "package_ndc": [
     "66794-160-02",
     "66794-162-02"
    ],
    "unii": [
     "X3P646A2J0"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Mitigo, Injection, 200 mg/20 mL (NDC 66794-160-02)",
   "company_name": "Piramal Critical Care Inc.",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "10/31/2017",
   "package_ndc": "0409-1890-01",
   "generic_name": "Morphine Sulfate Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA202515"
    ],
    "brand_name": [
     "MORPHINE SULFATE"
    ],
    "generic_name": [
     "MORPHINE SULFATE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-1890",
     "0409-1891",
     "0409-1892",
     "0409-1893",
     "0409-1894"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MORPHINE SULFATE"
    ],
    "rxcui": [
     "894912",
     "998212",
     "998213",
     "1729197",
     "1731995",
     "1732014"
    ],
    "spl_id": [
     "56671cfe-7548-442e-a2b5-ffebebf65ade"
    ],
    "spl_set_id": [
     "be420e8b-bcb0-49b5-bb4d-1df8b9959809"
    ],
    "package_ndc": [
     "0409-1890-03",
     "0409-1890-01",
     "0409-1890-13",
     "0409-1890-23",
     "0409-1891-03",
     "0409-1891-01",
     "0409-1891-13",
     "0409-1891-23",
     "0409-1892-03",
     "0409-1892-01",
     "0409-1892-13",
     "0409-1892-23",
     "0409-1893-03",
     "0409-1893-01",
     "0409-1893-13",
     "0409-1893-23",
     "0409-1894-03",
     "0409-1894-01"
    ],
    "unii": [
     "X3P646A2J0"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Morphine Sulfate, Injection, 2 mg/1 mL Syringes (NDC 0409-1890-01)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/03/2017",
   "package_ndc": "0641-6125-25",
   "generic_name": "Morphine Sulfate Injection",
   "contact_info": "800-631-2174",
   "availability": "Available",
   "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
   "openfda": {
    "application_number": [
     "ANDA205758"
    ],
    "brand_name": [
     "MORPHINE SULFATE"
    ],
    "generic_name": [
     "MORPHINE SULFATE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-6125",
     "0641-6126",
     "0641-6127"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MORPHINE SULFATE"
    ],
    "rxcui": [
     "1731993",
     "1732006",
     "1732011"
    ],
    "spl_id": [
     "fb513d10-94f4-45f5-8b30-fa82ef83e4e2"
    ],
    "spl_set_id": [
     "6023606c-150c-40c5-9175-598efe2a56c3"
    ],
    "package_ndc": [
     "0641-6126-01",
     "0641-6126-25",
     "0641-6127-01",
     "0641-6127-25",
     "0641-6125-01",
     "0641-6125-25"
    ],
    "unii": [
     "X3P646A2J0"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Morphine Sulfate, Injection, 4 mg/1 mL (NDC 0641-6125-25)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "12/06/2018",
   "package_ndc": "76329-1912-1",
   "generic_name": "Morphine Sulfate Injection",
   "contact_info": "800-423-4136",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA202861"
    ],
    "brand_name": [
     "MORPHINE SULFATE"
    ],
    "generic_name": [
     "MORPHINE SULFATE"
    ],
    "manufacturer_name": [
     "International Medication Systems, Limited"
    ],
    "product_ndc": [
     "76329-1912"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MORPHINE SULFATE"
    ],
    "spl_id": [
     "99799101-d92b-485b-93ec-f2b5a2e5ca26"
    ],
    "spl_set_id": [
     "1034467f-d436-4b87-a902-c7e8885daa8a"
    ],
    "package_ndc": [
     "76329-1912-0",
     "76329-1912-1"
    ],
    "unii": [
     "X3P646A2J0"
    ]
   },
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Morphine Sulfate, Injection, 1 mg/1 mL (NDC 76329-1912-1)",
   "company_name": "Amphastar Pharmaceuticals, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "10/31/2017",
   "package_ndc": "66794-162-02",
   "generic_name": "Morphine Sulfate Injection",
   "contact_info": "800-414-1901",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA204393"
    ],
    "brand_name": [
     "MITIGO"
    ],
    "generic_name": [
     "MORPHINE SULFATE"
    ],
    "manufacturer_name": [
     "Piramal Critical Care, Inc."
    ],
    "product_ndc": [
     "66794-162",
     "66794-160"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "EPIDURAL",
     "INTRATHECAL"
    ],
    "substance_name": [
     "MORPHINE SULFATE"
    ],
    "rxcui": [
     "1731522",
     "1731998",
     "2055307",
     "2055311"
    ],
    "spl_id": [
     "495a6a51-d35d-2b96-e063-6394a90ac5f3"
    ],
    "spl_set_id": [
     "728f3d83-9a63-0c1f-e053-2a91aa0ac7db"
    ],
    "package_ndc": [
     "66794-160-02",
     "66794-162-02"
    ],
    "unii": [
     "X3P646A2J0"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Mitigo, Injection, 500 mg/20 mL (NDC 66794-162-02)",
   "company_name": "Piramal Critical Care Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "10/31/2017",
   "package_ndc": "0409-1891-01",
   "generic_name": "Morphine Sulfate Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA202515"
    ],
    "brand_name": [
     "MORPHINE SULFATE"
    ],
    "generic_name": [
     "MORPHINE SULFATE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-1891",
     "0409-1890",
     "0409-1892",
     "0409-1893",
     "0409-1894"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MORPHINE SULFATE"
    ],
    "rxcui": [
     "894912",
     "998212",
     "998213",
     "1729197",
     "1731995",
     "1732014"
    ],
    "spl_id": [
     "56671cfe-7548-442e-a2b5-ffebebf65ade"
    ],
    "spl_set_id": [
     "be420e8b-bcb0-49b5-bb4d-1df8b9959809"
    ],
    "package_ndc": [
     "0409-1890-03",
     "0409-1890-01",
     "0409-1890-13",
     "0409-1890-23",
     "0409-1891-03",
     "0409-1891-01",
     "0409-1891-13",
     "0409-1891-23",
     "0409-1892-03",
     "0409-1892-01",
     "0409-1892-13",
     "0409-1892-23",
     "0409-1893-03",
     "0409-1893-01",
     "0409-1893-13",
     "0409-1893-23",
     "0409-1894-03",
     "0409-1894-01"
    ],
    "unii": [
     "X3P646A2J0"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Morphine Sulfate, Injection, 4 mg/1 mL Syringes (NDC 0409-1891-01)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "10/31/2017",
   "package_ndc": "0409-1893-01",
   "generic_name": "Morphine Sulfate Injection",
   "contact_info": "844-646-4398",
   "availability": "Unavailable",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA202515"
    ],
    "brand_name": [
     "MORPHINE SULFATE"
    ],
    "generic_name": [
     "MORPHINE SULFATE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-1893",
     "0409-1890",
     "0409-1891",
     "0409-1892",
     "0409-1894"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MORPHINE SULFATE"
    ],
    "rxcui": [
     "894912",
     "998212",
     "998213",
     "1729197",
     "1731995",
     "1732014"
    ],
    "spl_id": [
     "56671cfe-7548-442e-a2b5-ffebebf65ade"
    ],
    "spl_set_id": [
     "be420e8b-bcb0-49b5-bb4d-1df8b9959809"
    ],
    "package_ndc": [
     "0409-1890-03",
     "0409-1890-01",
     "0409-1890-13",
     "0409-1890-23",
     "0409-1891-03",
     "0409-1891-01",
     "0409-1891-13",
     "0409-1891-23",
     "0409-1892-03",
     "0409-1892-01",
     "0409-1892-13",
     "0409-1892-23",
     "0409-1893-03",
     "0409-1893-01",
     "0409-1893-13",
     "0409-1893-23",
     "0409-1894-03",
     "0409-1894-01"
    ],
    "unii": [
     "X3P646A2J0"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Morphine Sulfate, Injection, 10 mg/1 mL Syringes (NDC 0409-1893-01)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/03/2017",
   "package_ndc": "0641-6040-01",
   "generic_name": "Morphine Sulfate Injection",
   "contact_info": "800-631-2174",
   "availability": "Available",
   "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
   "openfda": {
    "application_number": [
     "NDA018565"
    ],
    "brand_name": [
     "INFUMORPH 500"
    ],
    "generic_name": [
     "MORPHINE SULFATE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-6040",
     "0641-6039"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "EPIDURAL",
     "INTRATHECAL"
    ],
    "substance_name": [
     "MORPHINE SULFATE"
    ],
    "rxcui": [
     "892652",
     "1731522",
     "1731998",
     "1731999"
    ],
    "spl_id": [
     "b1c060cb-5c5b-495f-90b5-044e04f2a3f2"
    ],
    "spl_set_id": [
     "db9ac9e3-d761-4a99-9f34-4946ebe8f255"
    ],
    "package_ndc": [
     "0641-6039-01",
     "0641-6040-01"
    ],
    "unii": [
     "X3P646A2J0"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Infumorph 500 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 25 mg/1 mL (NDC 0641-6040-01)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "10/31/2017",
   "package_ndc": "0409-3815-12",
   "generic_name": "Morphine Sulfate Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA073510"
    ],
    "brand_name": [
     "MORPHINE SULFATE"
    ],
    "generic_name": [
     "MORPHINE SULFATE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-3815",
     "0409-3814"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "EPIDURAL",
     "INTRATHECAL",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MORPHINE SULFATE"
    ],
    "rxcui": [
     "1728783",
     "1728800"
    ],
    "spl_id": [
     "0a2ba20b-448f-4412-9899-b82040ebfa7d"
    ],
    "spl_set_id": [
     "1d181906-f3ec-4222-1883-e61577a3122e"
    ],
    "package_ndc": [
     "0409-3814-11",
     "0409-3814-12",
     "0409-3815-11",
     "0409-3815-12"
    ],
    "unii": [
     "X3P646A2J0"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Morphine Sulfate, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-3815-12)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "10/31/2017",
   "package_ndc": "63323-455-01",
   "generic_name": "Morphine Sulfate Injection",
   "contact_info": "888-386-1300",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "NDA204223"
    ],
    "brand_name": [
     "MORPHINE SULFATE"
    ],
    "generic_name": [
     "MORPHINE SULFATE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-455",
     "63323-452",
     "63323-454",
     "63323-458",
     "63323-451"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MORPHINE SULFATE"
    ],
    "rxcui": [
     "1731993",
     "1732006",
     "1732011",
     "1732136",
     "2003714"
    ],
    "spl_id": [
     "dbf870e7-7bfe-48f0-ba6a-9cc476dfe5cc"
    ],
    "spl_set_id": [
     "582f42e5-444e-4246-af8c-e7e28097c69a"
    ],
    "package_ndc": [
     "63323-452-00",
     "63323-452-01",
     "63323-454-00",
     "63323-454-01",
     "63323-455-00",
     "63323-455-01",
     "63323-458-00",
     "63323-458-01",
     "63323-451-00",
     "63323-451-01"
    ],
    "unii": [
     "X3P646A2J0"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Morphine Sulfate, Injection, 5 mg/1 mL (NDC 63323-455-01)",
   "company_name": "Fresenius Kabi USA, LLC",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "10/31/2017",
   "package_ndc": "76045-005-11",
   "generic_name": "Morphine Sulfate Injection",
   "contact_info": "888-386-1300",
   "availability": "Unavailable",
   "related_info": "Next release date not available at this time. Check wholesalers for inventory.",
   "openfda": {
    "application_number": [
     "NDA204223"
    ],
    "brand_name": [
     "MORPHINE SULFATE"
    ],
    "generic_name": [
     "MORPHINE SULFATE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi, USA LLC"
    ],
    "product_ndc": [
     "76045-005",
     "76045-004",
     "76045-006",
     "76045-007",
     "76045-008"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MORPHINE SULFATE"
    ],
    "rxcui": [
     "894912",
     "894914",
     "998212",
     "998213",
     "1442790"
    ],
    "spl_id": [
     "286bce70-23cd-4d5b-989b-230d6cdd5a91"
    ],
    "spl_set_id": [
     "1f53de80-efc8-4930-b3e3-fba0d026af05"
    ],
    "package_ndc": [
     "76045-004-01",
     "76045-004-11",
     "76045-005-01",
     "76045-005-11",
     "76045-006-01",
     "76045-006-11",
     "76045-007-01",
     "76045-007-11",
     "76045-008-01",
     "76045-008-11"
    ],
    "unii": [
     "X3P646A2J0"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Morphine Sulfate, Injection, 4 mg/1 mL (NDC 76045-005-11)",
   "company_name": "Fresenius Kabi USA, LLC",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "10/31/2017",
   "package_ndc": "63323-452-01",
   "generic_name": "Morphine Sulfate Injection",
   "contact_info": "888-386-1300",
   "availability": "Available",
   "related_info": "Check wholesalers for inventory",
   "openfda": {
    "application_number": [
     "NDA204223"
    ],
    "brand_name": [
     "MORPHINE SULFATE"
    ],
    "generic_name": [
     "MORPHINE SULFATE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-452",
     "63323-454",
     "63323-455",
     "63323-458",
     "63323-451"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MORPHINE SULFATE"
    ],
    "rxcui": [
     "1731993",
     "1732006",
     "1732011",
     "1732136",
     "2003714"
    ],
    "spl_id": [
     "dbf870e7-7bfe-48f0-ba6a-9cc476dfe5cc"
    ],
    "spl_set_id": [
     "582f42e5-444e-4246-af8c-e7e28097c69a"
    ],
    "package_ndc": [
     "63323-452-00",
     "63323-452-01",
     "63323-454-00",
     "63323-454-01",
     "63323-455-00",
     "63323-455-01",
     "63323-458-00",
     "63323-458-01",
     "63323-451-00",
     "63323-451-01"
    ],
    "unii": [
     "X3P646A2J0"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Morphine Sulfate, Injection, 2 mg/1 mL (NDC 63323-452-01)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "10/31/2017",
   "package_ndc": "63323-451-01",
   "generic_name": "Morphine Sulfate Injection",
   "contact_info": "888-386-1300",
   "availability": "Available",
   "related_info": "Check wholesalers for inventory",
   "openfda": {
    "application_number": [
     "NDA204223"
    ],
    "brand_name": [
     "MORPHINE SULFATE"
    ],
    "generic_name": [
     "MORPHINE SULFATE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-451",
     "63323-452",
     "63323-454",
     "63323-455",
     "63323-458"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MORPHINE SULFATE"
    ],
    "rxcui": [
     "1731993",
     "1732006",
     "1732011",
     "1732136",
     "2003714"
    ],
    "spl_id": [
     "dbf870e7-7bfe-48f0-ba6a-9cc476dfe5cc"
    ],
    "spl_set_id": [
     "582f42e5-444e-4246-af8c-e7e28097c69a"
    ],
    "package_ndc": [
     "63323-452-00",
     "63323-452-01",
     "63323-454-00",
     "63323-454-01",
     "63323-455-00",
     "63323-455-01",
     "63323-458-00",
     "63323-458-01",
     "63323-451-00",
     "63323-451-01"
    ],
    "unii": [
     "X3P646A2J0"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Morphine Sulfate, Injection, 10 mg/1 mL (NDC 63323-451-01)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/03/2017",
   "package_ndc": "0641-6020-10",
   "generic_name": "Morphine Sulfate Injection",
   "contact_info": "800-631-2174",
   "availability": "Available",
   "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
   "openfda": {
    "application_number": [
     "NDA018565"
    ],
    "brand_name": [
     "DURAMORPH"
    ],
    "generic_name": [
     "MORPHINE SULFATE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-6020",
     "0641-6019"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "EPIDURAL",
     "INTRATHECAL",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MORPHINE SULFATE"
    ],
    "rxcui": [
     "892473",
     "892489",
     "1728783",
     "1728800"
    ],
    "spl_id": [
     "aa74af85-7068-4254-9a79-c7f3792044a6"
    ],
    "spl_set_id": [
     "ebb18761-e5c4-4238-bb84-f9549f500210"
    ],
    "package_ndc": [
     "0641-6020-01",
     "0641-6020-10",
     "0641-6019-01",
     "0641-6019-10"
    ],
    "unii": [
     "X3P646A2J0"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Duramorph, Injection, .5 mg/1 mL (NDC 0641-6020-10)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "11/03/2017",
   "package_ndc": "0641-6019-10",
   "generic_name": "Morphine Sulfate Injection",
   "contact_info": "800-631-2174",
   "availability": "Available",
   "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released.",
   "openfda": {
    "application_number": [
     "NDA018565"
    ],
    "brand_name": [
     "DURAMORPH"
    ],
    "generic_name": [
     "MORPHINE SULFATE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-6019",
     "0641-6020"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "EPIDURAL",
     "INTRATHECAL",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "MORPHINE SULFATE"
    ],
    "rxcui": [
     "892473",
     "892489",
     "1728783",
     "1728800"
    ],
    "spl_id": [
     "aa74af85-7068-4254-9a79-c7f3792044a6"
    ],
    "spl_set_id": [
     "ebb18761-e5c4-4238-bb84-f9549f500210"
    ],
    "package_ndc": [
     "0641-6020-01",
     "0641-6020-10",
     "0641-6019-01",
     "0641-6019-10"
    ],
    "unii": [
     "X3P646A2J0"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Analgesia/Addiction"
   ],
   "dosage_form": "Injection",
   "presentation": "Duramorph, Injection, 1 mg/1 mL (NDC 0641-6019-10)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "status": "Current"
  }
 ]
}